“We don’t just invest — we bring knowledge, network and opportunity,” says Edward De Nor, partner at GHO Capital, as he joins Bloomberg Intelligence analyst Jonathan Palmer to discuss how the firm identifies and scales mid-market health-care companies that enable better, faster, more accessible care. He explains GHO’s investment thesis, its “picks and shovels” strategy and how innovation, not disruption, fuels compounding growth. The two explore case studies like BioAgilytix, the role of AI as an enabler and why boardrooms should obsess over the customer, not just the P&L.

Ocular Therapeutix Cuts Blindness Toll
23:50

IRhythm Pushes a Proactive Approach to Monitoring
46:11

Pulse Biosciences Brings Differentiated Nanosecond Technology to PFA
45:16